Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 21203-68-9 | MDL No. : | MFCD04114179 |
Formula : | C6H6N2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | USZINSZJSVMICC-UHFFFAOYSA-N |
M.W : | 138.12 | Pubchem ID : | 2794552 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.17 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 38.02 |
TPSA : | 58.71 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.44 cm/s |
Log Po/w (iLOGP) : | 1.2 |
Log Po/w (XLOGP3) : | 0.99 |
Log Po/w (WLOGP) : | 1.3 |
Log Po/w (MLOGP) : | 0.41 |
Log Po/w (SILICOS-IT) : | -0.35 |
Consensus Log Po/w : | 0.71 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.7 |
Solubility : | 2.77 mg/ml ; 0.02 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.81 |
Solubility : | 2.13 mg/ml ; 0.0154 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.76 |
Solubility : | 2.38 mg/ml ; 0.0172 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.77 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
0.1 g | With oxygen; nitrogen(II) oxide In acetonitrile at 90℃; for 10 h; | Into the reactor, 0.93 g (10.0 mmol) of 2-methylpyridine, 5 mL of acetonitrile, 0.15 g of sulfonated graphene was added, and the reaction was stirred under an oxygen atmosphere at 5.0 MPa of nitrogen monoxide and a temperature of 90 ° C for 10 h. After the end of the reaction, nitrogen gas was introduced into the reaction mixture at a normal pressure until the nitrogen oxides completely escaped to the cold trap reaction receiver, and the catalyst was filtered off. The filtrate was washed with a 5percent (m/m) aqueous solution of sodium hydrogencarbonate to near neutral, and then washed with distilled water until the organic phase was neutral and concentrated by evaporation in vacuo. Separating the product components by column chromatography,The mass of 2-methylnitropyridine is 0.67g,Wherein 2-methyl-3-nitropyridine 0.10 g (mass fraction 16percent),2-methyl-5-nitropyridine 0.57 g (mass fraction 84percent), yield 49percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
94% | With selenium(IV) oxide In 1,4-dioxane for 16 h; Reflux | To a stirred solution of 2-methyl-5-nitropyridine (3.0 g, 0.021 mol, 1 eq) in 1 ,4- dioxane (30 mL) at room temperature was added selenium dioxide (2.9 g, 0.026 mol, 1.2 eq) and stirred at reflux for 16 h. The reaction mixture was filtered, evaporated, diluted with ethyl acetate (50 mL) and washed with water (50 mL), dried over sodium sulphate and evaporated to get 5-nitropicolinaldehyde (3.12g, 94 percent). |
94% | With selenium(IV) oxide In 1,4-dioxane for 16 h; Reflux | Step 1 To a stirred solution of 2-methyl-5-nitropyridine (3.0 g, 0.021 mol, 1 eq) in 1,4-dioxane (30 mL) at room temperature was added selenium dioxide (2.9 g, 0.026 mol, 1.2 eq) and stirred at reflux for 16 h. The reaction mixture was filtered, evaporated, diluted with ethyl acetate (50 mL) and washed with water (50 mL), dried over sodium sulfate and evaporated to get 5-nitropicolinaldehyde (3.12 g, 94percent). |
35% | Stage #1: With selenium(IV) oxide; water In 1,4-dioxane for 4 h; Heating / reflux Stage #2: With sodium hydrogencarbonate In 1,4-dioxane; diethyl ether; water |
A mixture of 2-methyl-5-nitropyridine (3 g), selenium (IV) (2.9 g), 1,4- dioxane (25 mL) and water (0.5 mL) was refluxed for 4 hrs. The resulting black solid was filtered through Celite° bed and washed with ether. The filtrate was treated with saturate aqueous NaHC03 and filtered again. The filtrate was extracted with ether twice and the solvent was concentrated. The residue was purified with a short silica gel column eluted with 20percent ethyl acetate in hexane to give 1.0 g of orange precipitate 2 (35percent yield). 1H NMR (CD2Cl2): 8 10.15 (s, 1H), 9.55 (s, 1H), 8.7 (d, 1H), 8.15 (s, 1H). |
[ 84531-36-2 ]
3-Nitro-6,7-dihydro-5H-cyclopenta[b]pyridine
Similarity: 0.86
[ 2229221-49-0 ]
2-(2-Bromoethyl)-5-nitropyridine
Similarity: 0.86
[ 51984-61-3 ]
2-Methyl-5-nitropyridin-3-amine
Similarity: 0.86
[ 2229221-49-0 ]
2-(2-Bromoethyl)-5-nitropyridine
Similarity: 0.86